Showing results (191-200 of 264) with videos related to

Sort By:
Pageof 27
Blood Research|October 11, 2016
Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working PartySeok Jin Kim, Soo-Mee Bang, Yoon Seok Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2022
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort StudyGrzegorz S Nowakowski, Dok Hyun Yoon, Anthea Peters, et al.
Annals of Hematology|June 21, 2014
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II studySeok Jin Kim, Deok-Hwan Yang, Jin Seok Kim, et al.
Cancer Biology & Therapy|July 5, 2011
p34 (SEI-1) inhibits ROS-induced cell death through suppression of ASK1Seung-Woo Hong, Jae-Sik Shin, Young-Min Lee, et al.
The Annals of Thoracic Surgery|September 11, 2012
Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancerChanghoon Yoo, Ji Hyun Park, Dok Hyun Yoon, et al.
Annals of Hematology|April 8, 2016
The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of KoreaHo Sup Lee, Chang-Ki Min, Je-Jung Lee, et al.
Annals of Laboratory Medicine|October 15, 2025
Clinico-hematopathologic and Genetic Characteristics of Korean Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Single-center Cohort StudyJiyeon Kim, Miyoung Kim, Daehyun Chu, et al.
Neuro-Oncology|August 4, 2024
Enhancing prognostication and treatment response evaluation in primary CNS lymphoma with 18F-FDG-PET/CTMinyoung Oh, Hyungwoo Cho, Ji Eun Park, et al.
Blood Advances|January 20, 2023
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 studyWon-Seog Kim, Noriko Fukuhara, Dok-Hyun Yoon, et al.
Blood Advances|August 15, 2023
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyAdam J Olszewski, Tycel J Phillips, Marc S Hoffmann, et al.
Pageof 27